Gruppo Farmaimpresa Successfully Concludes CPHI Milan 2024

Thank You for Visiting Our Stand at CPHI Milan Gruppo Farmaimpresa’s participation in CPHI Milan came to a very positive close, marking an important moment for meeting international professionals from the pharmaceutical and nutraceutical industries. The exhibition was a valuable opportunity to present our company as a food supplement and medical device manufacturer, as well…

Gruppo Farmaimpresa at Vitafoods Europe 2024

From May 14 to 16, 2024, Gruppo Farmaimpresa took part in Vitafoods Europe 2024 in Geneva, one of the most important international events dedicated to the nutraceutical and pharmaceutical industries. The exhibition was an important opportunity to present our expertise as a manufacturer of food supplements and medical devices, as well as a reliable partner…

Red Yeast Rice: Safety of Use Confirmed

Red Yeast Rice: Safety Under Review, Data in Hand Red yeast rice has long entered the daily routine of those seeking nutritional support for cholesterol control. In Europe as in Asia, supplements containing it are among the most widely used, often perceived as a “natural” solution and therefore, by definition, harmless. But is it really…

Monacolin K: EFSA Questions Its Safety

Red yeast rice, LDL cholesterol, dietary supplements, statins, European regulation For years, monacolin K has symbolized the meeting point between nutraceuticals and cholesterol management. Authorized with an official claim by EFSA, it has become firmly established in the dietary supplement market aimed at maintaining normal LDL cholesterol levels. Today, however, the scenario has changed. The…